MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in MiNK Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q3 2024
- Shares held
- 809.4K
- −37.2K (−4.4%) vs. Q3 2024
- Total value
- $564.9K
- −$67.4K (−10.7%) vs. Q3 2024
- New holders
- 2
- 4 more added
- Sold out
- 5
- 7 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INKT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.39M |
| Q1 2026 | 23 | $1.34M |
| Q4 2025 | 25 | $1.71M |
| Q3 2025 | 18 | $1.28M |
| Q2 2025 | 19 | $460.8K |
| Q1 2025 | 17 | $544.2K |
| Q4 2024 | 23 | $564.9K |
| Q3 2024 | 26 | $632.3K |
| Q2 2024 | 31 | $847.8K |
| Q1 2024 | 34 | $848.1K |
| Q4 2023 | 36 | $1.05M |
| Q3 2023 | 36 | $800.0K |
| Q2 2023 | 45 | $3.10M |
| Q1 2023 | 12 | $1.15M |
| Q4 2022 | 16 | $1.70M |
| Q3 2022 | 11 | $1.00M |
| Q2 2022 | 13 | $504.0K |
| Q1 2022 | 25 | $1.76M |
| Q4 2021 | 21 | $5.96M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding MiNK Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 234,182 | $163.2K | 0.00% | 00.0% | Unchanged |
| Longbow Finance SA | 166,666 | $116.2K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 101,707 | $70.9K | 0.00% | −4,980−4.7% | Reduced |
| Geode Capital Management, LLC | 96,113 | $67.0K | 0.00% | −1,868−1.9% | Reduced |
| BlackRock, Inc. | 88,281 | $61.5K | 0.00% | +155+0.2% | Added |
| HighTower Advisors, LLC | 50,676 | $35.3K | 0.00% | −1,052−2.0% | Reduced |
| State Street Corp | 25,515 | $17.8K | 0.00% | 00.0% | Unchanged |
| Greenwich Wealth Management LLC | 10,805 | $8.00K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,441 | $7.97K | 0.00% | +368+3.3% | Added |
| Wells Fargo & Company | 10,079 | $7.02K | 0.00% | −454−4.3% | Reduced |
| Tower Research Capital LLC (TRC) | 5,401 | $3.76K | 0.00% | +1,374+34.1% | Added |
| UBS Group AG | 2,847 | $1.98K | 0.00% | −3,365−54.2% | Reduced |
| Bank of America Corp | 2,039 | $1.42K | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 1,049 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,319 | $918 | 0.00% | −112−7.8% | Reduced |
| Morgan Stanley | 334 | $233 | 0.00% | −2−0.6% | Reduced |
| JPMorgan Chase & Co | 325 | $227 | 0.00% | +196+151.9% | Added |
| BNP Paribas Arbitrage, SA | 247 | $172 | 0.00% | +247 | New |
| Northwestern Mutual Wealth Management Co | 190 | $132 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 170 | $116 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 43 | $30 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 2 | $3 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $1 | 0.00% | +1 | New |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −15,322−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,937−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −309−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |